38th USJC Business Advisory Board Meeting

The Business Advisory Board (BAB) provides a platform based in Japan to integrate business leaders from diverse fields including government, academic and non-profit sectors to expand people-to-people connections to strengthen ties between the United States and Japan.

Behavior change in diabetes care has long been considered difficult—but that notion is now outdated. At our startup, we are working to prevent the onset and progression of diabetes through an innovative approach: once-weekly, low- or non-invasive home-based glucose monitoring combined with a mobile app. This simple yet powerful method empowers individuals, enhances self-efficacy, and supports sustainable lifestyle changes. In this talk, I will share insights from our latest device development and clinical research, and offer a vision for the future of healthcare—where behavioral science and technology come together to break stigma and enable proactive diabetes care.

Featured Speaker

Koshin Sekimizu, Ph.D.
President & CEO, Provigate, Inc.

Koshin Sekimizu is the founder and CEO of Provigate, a medtech startup pioneering a new model of diabetes care that combines once-weekly, low-/non-invasive glycated albumin (GA) monitoring with a digital behavior support app. He holds both a B.A. and Ph.D. in Biology from the University of Tokyo.

He began his career as a management consultant and later worked in private equity investment in Hong Kong. Since founding Provigate in 2015, he has led efforts to develop preventive healthcare technologies and is driving clinical research and real-world implementation in both Japan and the United States.